Literature DB >> 30336917

The hemodynamic and atrial electrophysiologic consequences of chronic left atrial volume overload in a controllable canine model.

Chawannuch Ruaengsri1, Matthew R Schill2, Timothy S Lancaster2, Ali J Khiabani2, Joshua L Manghelli2, Daniel I Carter2, Jason W Greenberg2, Spencer J Melby2, Richard B Schuessler2, Ralph J Damiano3.   

Abstract

OBJECTIVE: The purpose of this study was to determine the effects of chronic left atrial volume overload on atrial anatomy, hemodynamics, and electrophysiology using a titratable left ventriculoatrial shunt in a canine model.
METHODS: Canines (n = 16) underwent implantation of a shunt between the left ventricle and the left atrium. Sham animals (n = 8) underwent a median sternotomy without a shunt. Atrial activation times and effective refractory periods were determined using 250-bipolar epicardial electrodes. Biatrial pressures, systemic pressures, left atrial and left ventricle diameters and volumes, atrial fibrillation inducibility, and durations were recorded at the initial and at 6-month terminal study.
RESULTS: Baseline shunt fraction was 46% ± 8%. The left atrial pressure increased from 9.7 ± 3.5 mm Hg to 13.8 ± 4 mm Hg (P < .001). At the terminal study, the left atrial diameter increased from a baseline of 2.9 ± 0.05 cm to 4.1 ± 0.6 cm (P < .001) and left ventricular ejection fraction decreased from 64% ± 1.5% to 54% ± 2.7% (P < .001). Induced atrial fibrillation duration (median, range) was 95 seconds (0-7200) compared with 0 seconds (0-40) in the sham group (P = .02). The total activation time was longer in the shunt group compared with the sham group (72 ± 11 ms vs 62 ± 3 ms, P = .003). The right atrial and not left atrial effective refractory periods were shorter in the shunt compared with the sham group (right atrial effective refractory period: 156 ± 11 ms vs 141 ± 11 ms, P = .005; left atrial effective refractory period: 142 ± 23 ms vs 133 ± 11 ms, P = .35).
CONCLUSIONS: This canine model of mitral regurgitation reproduced the mechanical and electrical remodeling seen in clinical mitral regurgitation. Left atrial size increased, with a corresponding decrease in left ventricle systolic function, and an increased atrial activation times, lower effective refractory periods, and increased atrial fibrillation inducibility. This model provides a means to understand the remodeling by which mitral regurgitation causes atrial fibrillation.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  atrial fibrillation; mitral regurgitation

Mesh:

Year:  2018        PMID: 30336917      PMCID: PMC6935371          DOI: 10.1016/j.jtcvs.2018.05.078

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  27 in total

1.  Hemodynamic effects of quantitatively varied experimental mitral regurgitation.

Authors:  E BRAUNWALD; G H WELCH; S J SARNOFF
Journal:  Circ Res       Date:  1957-09       Impact factor: 17.367

2.  Left ventricular function in experimental volume overload hypertrophy.

Authors:  B A Carabello; K Nakano; W Corin; R Biederman; J F Spann
Journal:  Am J Physiol       Date:  1989-04

Review 3.  Ablation of atrial fibrillation with mitral valve surgery.

Authors:  A Marc Gillinov
Journal:  Curr Opin Cardiol       Date:  2005-03       Impact factor: 2.161

Review 4.  Expert consensus guidelines: Examining surgical ablation for atrial fibrillation.

Authors:  Niv Ad; Ralph J Damiano; Vinay Badhwar; Hugh Calkins; Mark La Meir; Takashi Nitta; Nicolas Doll; Sari D Holmes; Ali A Weinstein; Marc Gillinov
Journal:  J Thorac Cardiovasc Surg       Date:  2017-03-02       Impact factor: 5.209

5.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

6.  The effects of inflammation on heart rate and rhythm in a canine model of cardiac surgery.

Authors:  Richard B Schuessler; Yosuke Ishii; Yulian Khagi; Kelly Diabagate; John P Boineau; Ralph J Damiano
Journal:  Heart Rhythm       Date:  2011-10-04       Impact factor: 6.343

Review 7.  Atrial fibrillation driver mechanisms: Insight from the isolated human heart.

Authors:  Thomas A Csepe; Brian J Hansen; Vadim V Fedorov
Journal:  Trends Cardiovasc Med       Date:  2016-05-24       Impact factor: 6.677

8.  A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation.

Authors:  Sydney L Gaynor; Michael D Diodato; Sunil M Prasad; Yosuke Ishii; Richard B Schuessler; Marci S Bailey; Nicholas R Damiano; Jeffrey B Bloch; Marc R Moon; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2004-10       Impact factor: 5.209

9.  Alterations in electrophysiology and tissue structure of the left atrial posterior wall in a canine model of atrial fibrillation caused by chronic atrial dilatation.

Authors:  Min Tang; Shu Zhang; Qi Sun; Congxin Huang
Journal:  Circ J       Date:  2007-10       Impact factor: 2.993

10.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation.

Authors:  J L Cox; T E Canavan; R B Schuessler; M E Cain; B D Lindsay; C Stone; P K Smith; P B Corr; J P Boineau
Journal:  J Thorac Cardiovasc Surg       Date:  1991-03       Impact factor: 5.209

View more
  4 in total

1.  Association of RDW, NLR, and PLR with Atrial Fibrillation in Critical Care Patients: A Retrospective Study Based on Propensity Score Matching.

Authors:  Yao-Zong Guan; Rui-Xing Yin; Peng-Fei Zheng; Chun-Xiao Liu; Bi-Liu Wei; Guo-Xiong Deng
Journal:  Dis Markers       Date:  2022-05-27       Impact factor: 3.464

Review 2.  The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation.

Authors:  Xixiao Li; Anna Garcia-Elias; Begoña Benito; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

3.  Association between functional mitral regurgitation and recurrence of paroxysmal atrial fibrillation following catheter ablation: a prospective cohort study.

Authors:  Fusheng Ke; Yinhui Huang; Zhexiu Jin; Lei Huang; Qiang Xiong; Fang Jia; Yu Chen; Gang Chen
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  The Arrhythmic Substrate for Atrial Fibrillation in Patients with Mitral Regurgitation.

Authors:  Matthew R Schill; Phillip S Cuculich; Christopher M Andrews; Ramya Vijayakumar; Chawannuch Ruaengsri; Matthew C Henn; Timothy S Lancaster; Spencer J Melby; Richard B Schuessler; Yoram Rudy; Ralph J Damiano
Journal:  J Atr Fibrillation       Date:  2020-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.